| Literature DB >> 35581716 |
Sasitorn Chantaratin1, Kawita Trimetha1, Peerawong Werarak2, Keswadee Lapphra1, Alan Maleesatharn1,2, Supattra Rungmaitree1, Orasri Wittawatmongkol1, Wanatpreeya Phongsamart1, Nantaka Kongstan1, Benjawan Khumcha1, Kulkanya Chokephaibulkit1,3.
Abstract
Integrative mental health care in HIV patients is an important contributor to successful therapy. This is a cross-sectional study in youth and young adults who attend routine HIV clinic at a tertiary care centre in Bangkok. We recruited 100 youth and 130 young adults living with HIV to evaluate the frequency of depression and anxiety and associated sociodemographic including sexual orientation and health-related behaviours. Overall, about a fifth of the participants had significant depression or anxiety. Interestingly, we found different factors associated with depression in youth and young adults living with HIV. Loss of their father, loss of close relatives or friends, and being unemployed or school exclusion were the factors associate with depression in youth; while dangerous alcohol use, feeling discriminated against and having lipodystrophy were factors in young adults. The understanding of the frequency and different associated factors can inform more effective prevention and treatment strategies.Entities:
Keywords: HIV in asian setting; HIV-infected youth; mental health; psychosocial factors
Mesh:
Year: 2022 PMID: 35581716 PMCID: PMC9121500 DOI: 10.1177/23259582221101811
Source DB: PubMed Journal: J Int Assoc Provid AIDS Care ISSN: 2325-9574
Demographics and Clinical Characteristics of Youth and Young Adults (N = 230).
| Youth (N = 100)a | Young Adult (N = 130)a | Total | |
|---|---|---|---|
| Age (years); Median (IQR) | 19 (17–22) | 30 (27–33) | 26 (20–31) |
| Gender and sexual orientation by self-report; n (%) | |||
| Male, heterosexual | 35 (35.0) | 29 (22.3) | 64 (27.8) |
| Female, heterosexual | 52 (52.0) | 30 (23.1) | 82 (35.7) |
| LGBT | 13 (13.0) | 71 (54.6) | 84 (36.5) |
|
MSM | 10 (10.0) | 60 (46.2) | 70 (30.4) |
|
Bisexual | - | 5 (3.8) | 5 (2.2) |
|
TGW | 3 (3.0) | 6 (4.6) | 9 (3.9) |
| Mode of HIV acquisition; n (%) | |||
| Perinatal | 77 (77.0) | 4 (3.1) | 81 (35.2) |
| Sexual | 20 (20.0) | 126 (96.9) | 146 (63.5) |
| Transfusion | 1 (1.0) | 0 (0.0) | 1 (0.4) |
| Unknown | 2 (2.0) | 0 (0.0) | 2 (0.9) |
| Age at HIV diagnosed (years); median (IQR) | 3.5 (0.5–11) | 25 (23–28) | 21 (4–26) |
| Current CD4b cells/mm3; median (IQR) | 605 (443–830) | 561 (365–737) | 580 (384–768) |
| ≤200; n (%) | 4 (4.0) | 11 (8.5) | 15 (6.6) |
| 201–500; n (%) | 31 (31.0) | 40 (31.0) | 71 (31.0) |
| >500; n (%) | 65 (65.0) | 78 (60.5) | 143 (62.4) |
| Worst CDC clinical staging; n (%) | |||
| N | 21 (21.0) | 65 (50.0) | 86 (37.4) |
| A | 17 (17.0) | 18 (13.8) | 35 (15.2) |
| B | 29 (29.0) | 15 (11.5) | 44 (19.1) |
| C | 33 (33.0) | 32 (24.6) | 65 (28.3) |
| Current Viral Loadb; n (%) | |||
| Not available | 1 (1.0) | 6 (4.6) | 7 (3.0) |
| Undetectable (<40 copies/mL) | 81 (81.0) | 112 (86.2) | 193 (83.9) |
| 40–1000 copies/mL | 4 (4.0) | 4 (3.1) | 8 (3.5) |
| >1000 copies | 14 (14.0) | 8 (6.2) | 22 (9.6) |
| Duration of undetectable viral load (years); median (IQR) | n = 80 | n = 111 | n = 191 |
| ≤1 year; n (%) | 9 (11.3) | 13 (11.7) | 22 (11.5) |
| >1–5 years; n (%) | 17 (21.3) | 68 (61.3) | 85 (44.5) |
| >5 years; n (%) | 54 (67.5) | 30 (27.0) | 84 (44.0) |
| Current antiretroviral drugs composed with NRTI backbone; n (%) | |||
| EFV | 29 (29.0) | 83 (63.8) | 112 (48.7) |
| RPV | 22 (22.0) | 33 (25.4) | 55 (23.9) |
| DOR | 3 (3.0) | - | 3 (1.3) |
| LPV/r | 2 (2.0) | 6 (4.6) | 8 (3.5) |
| ATV/r | 27 (27.0) | 2 (1.5) | 29 (12.6) |
| ATV/COBI | 4 (4.0) | - | 4 (1.7) |
| DRV/r | - | 3 (2.3) | 3 (1.3) |
| EVG/COBI | 5 (5.0) | 1 (0.8) | 6 (2.6) |
| RAL | - | 1 (0.8) | 1 (0.4) |
| DTG | 1 (1.0) | - | 1 (0.4) |
| BIC | 1 (1.0) | - | 1 (0.4) |
| No antiretroviral treatment in the past 6 months | 2 (2.0) | - | 2 (0.9) |
| Adherence by current visit pill counts; n (%) | |||
| Good adherence (>90%); n (%) | 85 (85.0) | 126 (96.9) | 211 (91.7) |
| Poor adherence (<90%); n (%) | 15 (15.0) | 4 (3.1) | 19 (8.3) |
| Age at full self-disclosure (year); median (IQR) | 12.5 (11-14) | 25 (23-28) | 21 (13-26) |
| Having ongoing HIV or ART-related comorbiditiesc; n (%) | 32 (32.0) | 41 (31.5) | 73 (31.7) |
| Having ongoing nonHIV-related comorbiditiesd; n (%) | 20 (20.0) | 23 (17.7) | 43 (18.7) |
| History of admission within the past 3 years; n (%) | 21 (21.0) | 32 (24.6) | 53 (23.0) |
| Presence of lipodystrophy; n (%) | 5 (5.0) | 3 (2.3) | 8 (3.5) |
Notes: IQR: interquartile range, LGBT: Lesbian, Gay, Bisexual, Transgender, MSM: men who have sex with men, TGW: transgender women, CDC: Center for Disease Control and Prevention, Clinical staging N: Asymptomatic, A: Mildly symptomatic HIV, B: Moderately symptomatic HIV not A or C conditions, C: Severely symptomatic with AIDS-defining conditions, NRTI: nucleoside reverse transcriptase inhibitors, EFV: efavirenz, RPV: rilpivirine, DOR: doravirine, LPV/r: lopinavir with ritonavir, ATV/r: atazanavir with ritonavir, ATV/COBI: atazanavir with cobicistat, DRV/r: darunavir with ritonavir, EVG/COBI: elvitegravir with cobicistat, RAL: raltegravir, DTG: dolutegravir, BIC: bictegravir.
Denominator, unless otherwise indicated.
Result of the tests within 12 months.
The numbers of youth participants with the conditions were: 16 for dyslipidemia; 10 for hyperbilirubinemia; 5 for retinitis; 2 for TB infection; 2 for HIV encephalopathy; 1 for HIV-related dermatitis, and 1 for transaminitis. The numbers of young adult participants with the conditions were: 11 for dyslipidemia; 8 for transaminitis; 2 for Tuberculosis; 3 for carcinoma in situ neoplasm; 2 for Mycobacterium avium complex infection; 2 for impaired blood sugar; 1 for IRIS; 1 for lymphoma; 1 for pneumocystis pneumonia (PCP), and 1 for Kaposi sarcoma.
The numbers of youth participants with the conditions were: 4 for allergic rhinitis; 4 for mild intellectual deficit; 3 for hypertension; 2 for iron deficiency anemia; 2 for Thalassemia; 1 for Primary pulmonary hypertension; 1 for Turner syndrome; 1 for alopecia universalis; 1 for Vitiligo; 1 for Vitamin D deficiency, and 1 for asthma. The numbers of young adult participants with the conditions were: 4 for hypertension; 3 for obesity; 3 for Thalassemia; 2 for Grave‘s disease; 2 for Psoriasis; 2 for fatty liver; 2 for end stage renal disease; 1 for Type 1 diabetes; 1 for hemorrhoid; 1 for venous sinus thrombosis; 1 for migraine; 1 for chronic otitis media; 1 for allergic rhinitis; 1 for splenic harmatoma; 1 for anal fistula; 1 for cataract, and 1 for thyroid carcinoma.
Sociodemographic and Health Related Behaviors of the Study Sample (N = 230).
| Youth (N = 100)a | Young Adult (N = 130)a | Total | |
|---|---|---|---|
| Employment; n (%) | |||
| Unemployed/ Housework | 12 (12.0) | 9 (6.9) | 21 (9.1) |
| Student | 56 (56.0) | 4 (3.1) | 60 (26.1) |
| Employed/ Working | 32 (32.0) | 117 (90.0) | 149 (64.8) |
| Highest Education; n (%) | |||
| Never attend school | 2 (2.0) | - | 2 (0.9) |
| High school and less | 54 (54.0) | 37 (28.5) | 91 (39.6) |
| Diploma degree | 15 (15.0) | 8 (6.2) | 23 (10.0) |
| Bachelor degree | 28 (28.0) | 68 (52.3) | 96 (41.7) |
| Master degree and above | 1 (1.0) | 17 (13.1) | 18 (7.8) |
| GPA (only in student); n (%) | N = 56 | N = 4 | N = 60 |
| ≥3.00 | 14 (25.0) | 1 (25.0) | 15 (25.0) |
| 2.00–2.99 | 30 (53.6) | - | 30 (50.0) |
| <2.00 | 2 (3.6) | - | 2 (3.3) |
| No answer | 10 (17.9) | 3 (75.0) | 13 (21.7) |
| Living home during childhood; n (%) | |||
| Biological family | 98 (98.0) | 130 (100.0) | 228 (99.0) |
| Orphanage | 1 (1.0) | - | 1 (0.5) |
| Foster family | 1 (1.0) | - | 1 (0.5) |
| Current relationship with sex partner; n (%) | |||
| Single or no sex partner | 66 (66.0) | 56 (43.1) | 122 (53.0) |
| In relationship but not moving in | 24 (24.0) | 28 (21.5) | 52 (22.6) |
| Living together | 10 (10.0) | 46 (35.4) | 56 (24.3) |
| HIV status disclosed to partner; n (%) | 18 (52.9) | 22 (29.7) | 30 (27.8) |
| Partner‘s HIV status; n (%) | |||
| Positive | 1 (2.9) | 33 (45.8) | 34 (32.1) |
| Negative | 26 (76.5) | 32 (44.4) | 58 (54.7) |
| Unknown | 7 (20.6) | 7 (9.7) | 14 (13.2) |
| Father‘s status; n (%) | |||
| Alive | 65 (65.0) | 107 (82.3) | 172 (74.8) |
| Died | 34 (34.0) | 20 (15.4) | 54 (23.5) |
| Unknown | 1 (1.0) | 3 (2.3) | 4 (1.7) |
| Age at losing father (years); median (IQR) | n = 34 | n = 20 | n = 64 |
| Mother‘s status; n (%) | |||
| Alive | 67 (67.0) | 118 (90.8) | 185 (80.4) |
| Died | 33 (33.0) | 9 (6.9) | 42 (18.3) |
| Unknown | - | 3 (2.3) | 3 (1.3) |
| Age at losing mother (years); median (IQR) | (n = 33) | (n = 9) | (n = 42) |
| Current supportive household member; n (%) | |||
| Parents | 50 (50.0) | 47 (36.2) | 97 (42.2) |
| Relatives | 38 (38.0) | 34 (26.2) | 72 (31.3) |
| Partner | 9 (9.0) | 45 (34.6) | 54 (23.5) |
| Daughter/Son | - | 11 (8.5) | 11 (4.8) |
| Alone | 8 (8.0) | 32 (24.6) | 40 (17.4) |
| Current alcohol consumption score; n (%) | |||
| Dangerous (by AUDIT) | 11 (11.0) | 13 (10.0) | 24 (10.4) |
| Social drink | 34 (34.0) | 40 (30.8) | 74 (32.2) |
| Never | 55 (55.0) | 77 (59.2) | 132 (57.4) |
| Using substances other than alcohol; n (%) | |||
| Never | 93 (93.0) | 108 (83.1) | 201 (87.4) |
| Ever | 5 (5.0) | 21 (16.2) | 26 (11.3) |
| Currently using | 2 (2.0) | 1 (0.8) | 3 (1.3) |
| Currently smoking; n (%) | 19 (19.2) | 23 (17.8) | 42 (18.4) |
| Income per month (Thai baht); median (IQR) | 10000 (7000–15000) | 19000 (15000–25000) | 16000 (12000–22530) |
| ≤10000 | 18 (60.0) | 13 (10.9) | 31 (20.8) |
| 10001–30000 | 12 (40.0) | 91 (76.5) | 103 (69.1) |
| 30001–60000 | - | 12 (10.1) | 12 (8.1) |
| >60000 | - | 3 (2.5) | 3 (2.0) |
| Felt discriminated against or stigmatized; n (%) | 8 (8.0) | 20 (15.4) | 28 (12.2) |
| Hobbies; n (%) | |||
| Having leisure time without specific activity | 95 (95.0) | 128 (98.5) | 223 (97.0) |
| Playing games | 42 (42.0) | 52 (40.0) | 94 (40.9) |
| Using social media | 68 (68.0) | 77 (59.2) | 145 (63.0) |
| Playing sports | 19 (19.0) | 44 (33.8) | 63 (27.4) |
| Watching TV/Listening to music | 60 (60.0) | 80 (61.5) | 140 (60.9) |
| Reading books | 16 (16.0) | 18 (13.8) | 34 (14.8) |
| Duration of sleep; median (IQR) | 8 (7–8) | 8 (7–8) | 8 (7–8) |
| >8 hours; n (%) | 19 (19.4) | 18 (13.8) | 37 (16.2) |
| 6–8 hours; n (%) | 74 (75.5) | 107 (82.3) | 181 (79.4) |
| <6 hours; n (%) | 5 (5.1) | 5 (3.8) | 10 (4.4) |
| Number of current partners; median (IQR) | 0 (0–1) | 1 (0–1) | 0 (0–1) |
| No partner; n (%) | 70 (70.0) | 50 (39.4) | 120 (52.9) |
| 1; n (%) | 28 (28.0) | 75 (59.1) | 103 (45.4) |
| Multiple partners; n (%) | 2 (2.0) | 2 (1.6) | 4 (1.8) |
| Ever had sexual intercourse; n (%) | |||
| Yes | 52 (52.0) | 117 (90.0) | 169 (73.5) |
| No | 43 (43.0) | 1 (0.8) | 44 (19.1) |
| No answer | 5 (5.0) | 12 (9.2) | 17 (7.4) |
| Frequency of condom using; median (IQR) | |||
| Always use condom; n (%) | 32 (61.5) | 72 (61.5) | 104 (61.5) |
| Use condom for sometimes; n (%) | 14 (26.9) | 37 (31.6) | 51 (30.2) |
| Never use condom; n (%) | 6 (11.5) | 8 (6.8) | 14 (8.3) |
| Ever had STD; n (%) | 11 (11.0) | 46 (35.4) | 57 (24.8) |
| Stressful event in the past 12 months; n (%) | |||
| Loss of close relatives or friends | 20 (20.0) | 33 (25.4) | 53 (23.0) |
| Broke up with partner | 13 (13.0) | 20 (15.4) | 33 (14.3) |
| Being assaulted | 5 (5.0) | 8 (6.2) | 13 (5.7) |
| No work/ Unemployed/ School exclusion | 15 (15.0) | 22 (16.9) | 37 (16.1) |
| Having someone to talk to or get help; n (%) | |||
| Having someone to talk to when needed | 83 (83.0) | 100 (76.9) | 183 (79.6) |
| Having loved ones | 94 (94.0) | 125 (96.2) | 219 (95.2) |
| Having someone who can trust | 91 (91.0) | 117 (90.0) | 208 (90.4) |
| Having someone to provide financial support | 86 (86.0) | 113 (86.9) | 199 (86.5) |
Notes: NA: not answer/ not available, GPA: grade point average, IQR: interquartile range, AUDIT: alcohol use identification test, STD: sexual transmitted diseases.
Denominator, unless otherwise indicated.
Figure 1.Mental health screening outcomes. 1a) Youth group, 1b) Young adult group. The Thai version of the 9-item depression scale from the Patient Health Questionnaire (PHQ −9) and modified PHQ-9 for Adolescents (PHQ-A) were used to evaluate depression in adults and adolescents, respectively. Depression was defined as having PHQ-A score of ≥ 10 or PHQ-9 of ≥ 9. The Child Anxiety Related Disorder (SCARED) and the 7-item anxiety scale (GAD-7) were used to evaluate anxiety in youth in young adults, respectively. Anxiety was defined as having SCARED score of ≥ 25 or GAD-7 of ≥ 10 to identify anxiety disorder.
Factors Associated with Depression in Youths – Multivariable Analysis.
| Factors | No Depression (N = 85) | Depression (N = 15) | Crude OR (95%CI) | Adjusted OR (95%CI) | ||
|---|---|---|---|---|---|---|
| Gender; n (%) | ||||||
| Heterosexual male | 32 (91.4) | 3 (8.6) | 1 | |||
| Heterosexual female | 41 (78.8) | 11 (21.2) | 2.9 (0.7–11.1) | 0.129 | ||
| LGBT + | 12 (92.3) | 1 (7.7) | 0.9 (0.1–9.4) | 0.922 | ||
| Father‘s status; n (%) | ||||||
| Alive | 58 (89.2) | 7 (10.8) | 1 | 1 | ||
| Died | 26 (76.5) | 8 (23.5) | 2.5 (0.8–7.8) | 0.100 | 4.8 (1.03–22.6) | 0.045 |
| Unknown | 1 (100.0) | 0 (0.0) | - | - | - | - |
| Mother‘s status; n (%) | ||||||
| Alive | 58 (86.6) | 9 (13.4) | 1 | |||
| Died | 27 (81.8) | 6 (18.2) | 1.4 (0.5–4.4) | 0.533 | ||
| Unknown | - | - | ||||
| Relationship with sex partner; n (%) | ||||||
| Single or no relationship | 54 (81.8) | 12 (18.2) | 1 | |||
| In relationship | 22 (91.7) | 2 (8.3) | 0.4 (0.1–2.0) | 0.267 | ||
| Living together | 9 (90.0) | 1 (10.0) | 0.5 (0.1–4.3) | 0.529 | ||
| Adherence to antiretroviral treatment | ||||||
| Good adherence (>90%) | 75 (88.2) | 10 (11.8) | 1 | - | ||
| Poor adherence (<90%) | 10 (66.7) | 5 (33.3) | 3.8 (1.1–13.2) | 0.040 | - | - |
| Current viral load; n (%) | ||||||
| Undetectable (<40 copies/mL) | 71 (87.7) | 10 (12.3) | 1 | - | ||
| 40–1000 copies/mL | 2 (50.0) | 2 (50.0) | 7.1 (0.9–56.2) | 0.063 | - | - |
| >1000 copies/mL | 11 (78.6) | 3 (21.4) | 1.9 (0.5–8.2) | 0.368 | - | - |
| Current alcohol consumption score; n (%) | ||||||
| Dangerous (by AUDIT) | 10 (90.9) | 1 (9.1) | 0.7 (0.1–6.2) | 0.737 | ||
| Social drink | 27 (79.4) | 7 (20.6) | 1.8 (0.6–5.6) | 0.326 | ||
| Never | 48 (87.3) | 7 (12.7) | 1 | |||
| Using substance other than alcohol; n (%) | ||||||
| Never | 79 (84.9) | 14 (15.1) | 1 | |||
| Ever | 4 (80.0) | 1 (20.0) | 1.4 (0.1–13.6) | 0.766 | ||
| Currently using | 2 (100.0) | 0 (0.0) | - | - | ||
| Currently smoking; n (%) | ||||||
| Yes | 15 (78.9) | 4 (21.1) | 1.7 (0.5–6.1) | 0.416 | ||
| No | 70 (86.4) | 11 (13.6) | 1 | |||
| Using social media; n (%) | ||||||
| Yes | 55 (80.9) | 13 (19.1) | 3.5 (0.7–16.8) | 0.110 | 4.1 (0.7–24.8) | 0.122 |
| No | 30 (93.8) | 2 (6.3) | 1 | 1 | ||
| Loss of close relatives or friends; n (%) | ||||||
| Yes | 13 (65.0) | 7 (35.0) | 4.8 (1.5–15.7) | 0.008 | 8.1 (1.6–41.3) | 0.011 |
| No | 72 (90.0) | 8 (10.0) | 1 | 1 | ||
| No work/ Unemployed/ School exclusion; n (%) | ||||||
| Yes | 7 (46.7) | 8 (53.3) | 12.7 (3.6–45.6) | <0.001 | 14.7 (3.1–68.9) | 0.001 |
| No | 78 (91.8) | 7 (8.2) | 1 | 1 | ||
| Felt discriminated against or stigmatized; n (%) | ||||||
| Yes | 7 (87.5) | 1 (12.5) | 0.8 (0.1–7.0) | 0.837 | ||
| No | 78 (84.8) | 14 (15.2) | 1 | |||
| Presence of lipodystrophy; n (%) | ||||||
| Yes | 4 (80.0) | 1 (20.0) | 1.4 (0.2–13.9) | 0.749 | ||
| No | 81 (85.3) | 14 (14.7) | 1 | |||
| Having someone to talk to when needed; n (%) | ||||||
| Yes | 71 (85.5) | 12 (14.5) | 0.8 (0.2–3.2) | 0.738 | ||
| No | 14 (82.4) | 3 (17.6) | 1 |
Factors Associated with Depression in Young Adults – Multivariable Analysis.
| Factors | No Depression (N = 105) | Depression (N = 25) | Crude OR (95%CI) | Adjusted OR (95%CI) | ||
|---|---|---|---|---|---|---|
| Gender; n (%) | ||||||
| Heterosexual male | 20 (69.0) | 9 (31.0) | 1 | - | ||
| Heterosexual female | 26 (86.7) | 4 (13.3) | 0.3 (0.1–1.3) | 0.109 | - | - |
| LGBT + | 59 (83.1) | 12 (16.9) | 0.4 (0.2–1.2) | 0.120 | - | - |
| Father‘s status; n (%) | ||||||
| Alive | 83 (77.6) | 24 (22.4) | 1 | 1 | ||
| Died | 19 (95.0) | 1 (5.0) | 0.2 (0.02–1.4) | 0.105 | 0.08 (0.01–0.76) | 0.028 |
| Unknown | 3 (100.0) | 0 (0.0) | - | - | - | - |
| Mother‘s status; n (%) | ||||||
| Alive | 95 (80.5) | 23 (19.5) | 1 | |||
| Died | 7 (77.8) | 2 (22.2) | 1.2 (0.2–6.1) | 0.843 | ||
| Unknown | 3 (100.0) | - | - | - | ||
| Relationship with sex partner; n (%) | ||||||
| Single or no relationship | 49 (87.5) | 7 (12.5) | 1 | - | ||
| In relationship | 19 (67.9) | 9 (32.1) | 3.3 (1.1–10.2) | 0.036 | - | - |
| Living together | 37 (80.4) | 9 (19.6) | 1.7 (0.6–5.0) | 0.332 | - | - |
| Adherence to antiretroviral treatment | ||||||
| Good adherence (>90%) | 102 (81.0) | 24 (19.0) | 1 | |||
| Poor adherence (<90%) | 3 (75.0) | 1 (25.0) | 1.4 (0.1–14.2) | 0.767 | ||
| Current viral load; n (%) | ||||||
| Undetectable (<40 copies/mL) | 91 (81.3) | 21 (18.8) | 1 | - | ||
| 40–1000 copies/mL | 2 (50.0) | 2 (50.0) | 4.3 (0.6–32.6) | 0.154 | - | - |
| >1000 copies/mL | 7 (87.5) | 1 (12.5) | 0.6 (0.1–5.3) | 0.662 | - | - |
| Current alcohol consumption score; n (%) | ||||||
| Dangerous (by AUDIT) | 7 (53.8) | 6 (46.2) | 5.1 (1.5–18.2) | 0.011 | 9.0 (1.8–46.3) | 0.008 |
| Social drink | 32 (80.0) | 8 (20.0) | 1.5 (0.5–4.0) | 0.429 | 23 (0.7–7.9) | 0.184 |
| Never | 66 (85.7) | 11 (14.3) | 1 | 1 | ||
| Using substance other than alcohol; n (%) | ||||||
| Never | 90 (83.3) | 18 (16.7) | 1 | 1 | ||
| Ever | 14 (66.7) | 7 (33.3) | 2.5 (0.9–7.1) | 0.084 | 2.5 (0.7–9.3) | 0.164 |
| Currently using | 1 (100.0) | 0 (0.0) | - | - | - | - |
| Currently smoking; n (%) | ||||||
| Yes | 15 (65.2) | 8 (34.8) | 2.8 (1.04–7.7) | 0.042 | - | - |
| No | 90 (84.1) | 17 (15.9) | 1 | - | ||
| Using social media; n (%) | ||||||
| Yes | 64 (83.1) | 13 (16.9) | 0.7 (0.3–1.7) | 0.414 | ||
| No | 41 (77.4) | 12 (22.6) | 1 | |||
| Loss of close relatives or friends; n (%) | ||||||
| Yes | 26 (78.8) | 7 (21.2) | 1.2 (0.4–3.1) | 0.738 | ||
| No | 79 (81.4) | 18 (18.6) | 1 | |||
| No work/ Unemployed/ School exclusion; n (%) | ||||||
| Yes | 17 (77.3) | 5 (22.7) | 1.3 (0.4–3.9) | 0.649 | ||
| No | 88 (81.5) | 20 (18.5) | 1 | |||
| Felt discriminated against or stigmatized; n (%) | ||||||
| Yes | 11 (55.0) | 9 (45.0) | 4.8 (1.7–13.4) | 0.003 | 8.3 (2.2–30.9) | 0.002 |
| No | 94 (85.5) | 16 (14.5) | 1 | 1 | ||
| Presence of lipodystrophy; n (%) | ||||||
| Yes | 1 (33.3) | 2 (66.7) | 9.0 (0.8–104.0) | 0.077 | 28.7 (2.1–387.3) | 0.012 |
| No | 104 (81.9) | 23 (18.1) | 1 | 1 | ||
| Having someone to talk to when needed; n (%) | ||||||
| Yes | 86 (86.0) | 14 (14.0) | 0.3 (0.1–0.7) | 0.008 | 0.25 (0.07–0.82) | 0.023 |
| No | 19 (63.3) | 11 (36.7) | 1 | 1 |